Titulaire
KOMTUR PHARMACEUTICALS
Mogosoaia · ROU
Attributions
6
Montant total attribué
—
6 attribution(s) conjointe(s) comptée(s) au prorata
Acheteurs publics
2
Secteurs
1
Groupe: KOMTUR PHARMACEUTICALS
USt-IdNr. RO38459656
Marchés de ce titulaire arrivant à échéance
6 mai 2027
estiméeDINUTUXIMAB BETA 4,5 mg/ml32 828 443 RONSpitalul Clinic de Urgenta pentru Copii "Sf.Maria" IasiALLIANCE HEALTHCARE ROMANIA, KOMTUR PHARMACEUTICALS
8 sept. 2027
estimée69 DINUTUXIMAB BETA **1 FL. CONC. PT. SOL. PERF. 4,5 mg/ml5 277 514 RONInstitutul Oncologic Prof. Dr. I. Chiricuta Cluj-NapocaALLIANCE HEALTHCARE ROMANIA, KOMTUR PHARMACEUTICALS
10 sept. 2027
estimée76 SILTUXIMABUM FL. PULB. PT. CONC. PT. SOL. PERF. / 400 mg20 755 988 RONInstitutul Oncologic Prof. Dr. I. Chiricuta Cluj-NapocaALLIANCE HEALTHCARE ROMANIA, KOMTUR PHARMACEUTICALS
10 sept. 2027
estimée75 SILTUXIMABUM FL. PULB. PT. CONC. PT. SOL. PERF. / 100 mg7 933 651 RONInstitutul Oncologic Prof. Dr. I. Chiricuta Cluj-NapocaALLIANCE HEALTHCARE ROMANIA, KOMTUR PHARMACEUTICALS
7 oct. 2027
estiméeDINUTUXIMAB BETA 4,5 mg/ml33 042 669 RONSpitalul Clinic de Urgenta pentru Copii "Sf.Maria" IasiALLIANCE HEALTHCARE ROMANIA, KOMTUR PHARMACEUTICALS
7 oct. 2027
estiméeDINUTUXIMAB BETA 4,5 mg/ml33 214 050 RONSpitalul Clinic de Urgenta pentru Copii "Sf.Maria" IasiALLIANCE HEALTHCARE ROMANIA, KOMTUR PHARMACEUTICALS
Tous les marchés arrivant à échéance →